Concepts and misconceptions in oral anticoagulation – MM1611
While there is still a place for vitamin K antagonists (VKAs)/warfarin in anticoagulation therapy, the direct oral anticoagulants or DOACs (previously termed the new oral anticoagulants or NOACs) offer an advantage in every possible respect.
This was the take-home message in a series of talks given recently by Professor Jan Beyer-Westendorf, head of the Thrombosis Research Unit at the Centre for Vascular Medicine, University Hospital ‘Carl Gustav Carus’ in Dresden, Germany. as a guest of Bayer. He stated categorically that nowadays he only uses VKAs in selected patients when it’s unavoidable.
Modern Medicine – November 2016
